Nip stated he had personally requested senior administration of China’s Fosun Pharma to ship a brand new batch of the vaccines to Hong Kong if there have been security issues with the prevailing ones, the SCMP reported.
The BioNTech vaccine is distributed in Hong Kong and Macau via a partnership with Fosun Pharma. BioNTech companions with Pfizer Inc in markets exterior larger China.
BioNTech stated on March 24, it had determined to pause additional vaccination with the batch till the investigation is full as a precautionary measure and that no different batches shipped to different areas are affected by this investigation.
Persons are anticipated to get their booster dose earlier than mid-April, Nip stated on a radio present, in keeping with the SCMP report. “We are going to give precedence to those that want the second dose once we assign the brand new time slots and venues as soon as the vaccinations with BioNTech can resume,” the report added.
Hong Kong and Macau halted the usage of a Covid-19 vaccine developed by BioNTech on Wednesday, citing faulty packaging, in a transfer that triggered scenes of confusion in inoculation centres throughout the town.